-+ 0.00%
-+ 0.00%
-+ 0.00%

Lung Kee Group Holdings (SEHK:255) Stock Yield Looks Exposed As Losses Deepen

Simply Wall St·08/22/2026 20:17:09
Listen to the news

Traders barely moved on Lung Kee Group Holdings today, with the stock flat over the past week and month even as fresh half year numbers hit the tape. That calm surface hides a harsher reality for longer term holders. The mould base manufacturer is still loss making, with first half 2026 earnings per share in a small loss and trailing 12 month income also in the red. The bigger story now sits on the balance between those persistent losses and a dividend yield of 16.55% that current earnings and cash generation do not cover.

Love the headline 16.55% yield from Lung Kee Group Holdings but concerned about those ongoing losses and dividend coverage risk? Check out 422 dividend fortresses if you want income ideas backed by stronger balance sheets and more sustainable cash flows.

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs. H1 2025): HK$586.806 million vs. HK$688.654 million (a decline of 14.8%)
  • Net Loss (H1 2026 vs. H1 2025): HK$10.364 million loss vs. HK$3.553 million loss (the loss widened by 191.7%)
  • Basic EPS (H1 2026 vs. H1 2025): loss of HK$0.0163 per share vs. loss of HK$0.005624 per share (the loss per share increased by 189.8%)
  • Trailing 12 Month Net Loss (to H1 2026 vs. to H1 2025): HK$29.427 million loss vs. HK$6.689 million profit (shifted from profit to loss over the period)

Prefer clean charts over trawling through dense tables of red ink and dividend math for Lung Kee Group Holdings? Get a full visual view of the company, with a focus on its dividend history and sustainability, in the company report for Lung Kee Group Holdings.

SEHK:255 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
SEHK:255 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Lung Kee bullish hopes meet weaker earnings base

For anyone leaning bullish on Lung Kee Group Holdings as a mature industrial backbone, the latest figures make that stance harder to support in the near term. Revenue in H1 2026 is lower than H1 2025 and losses have increased at both the half-year and trailing 12-month level. That points to softer operating conditions rather than cyclical recovery. The share price has been broadly flat over 7 and 90 days, which suggests investors are not yet treating this as a clear earnings turnaround story.

Bearish worries on losses and coverage look reinforced

The more cautious narrative around Lung Kee Group Holdings finds firmer footing in these results. Revenue has fallen year on year and the net result has shifted from trailing profit to trailing loss. The widening loss in H1 2026 underlines pressure on the core industrial business at a time when the company is paying a high dividend yield that recent earnings do not support. With the share price largely unchanged over recent weeks, the market seems to accept the dividend but is not signalling confidence in a quick profit recovery.

After a 65.4% annual decline in earnings over five years and a 16.55% dividend that lacks cover, you may want to review the risk analysis for Lung Kee Group Holdings which shows 2 important warning signs to see whether these visible issues point to deeper operational or balance sheet vulnerabilities.

Stay Ahead With Simply Wall St

If the mix of flat recent performance and uncovered 16.55% dividend from Lung Kee Group Holdings has your attention, register for free with Simply Wall St and add the stock to a Watchlist so you can track price against fair value and wait for a setup that fits your plan. Once you decide to own it or any other stock, keep on top of what matters most with the Portfolio Command Center, which filters out noise and surfaces key changes to fundamentals, dividends and risks. For a longer term view, tap into the crowd wisdom and varied investor opinions inside the Community to stress test your own thesis. This can help you identify hidden catalysts and potential risks early so you stay a step ahead of the market.

Seeking Alternatives Beyond Lung Kee Group Holdings

Fresh ideas move first and stale ideas can get caught flat. Scan under-the-radar-for-now stocks before momentum builds and the best entry points drop away. Consider acting early rather than waiting for sentiment to shift.

  • Spot potential income players with staying power by scanning a curated pool of 422 dividend fortresses. Focus on yields and balance sheet strength while they still look attractive, before the wider market pays attention.
  • Hunt for resilient potential compounders by checking a hand picked list of solid balance sheet and fundamentals stocks (425 results) to find businesses where steadier finances support any share price momentum.
  • Explore the next wave of AI infrastructure opportunities by shortlisting 55 AI infrastructure stocks that could be positioned to participate in ongoing spending on data centers and chips.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.